Better High-Yield Dividend Stock to Buy: Bristol Myers Squibb or Pfizer?
Source: Motley Fool
2026-06-04 02:50:00 ET
When it comes to pharmaceutical stocks and yield, Bristol Myers Squibb (NYSE: BMY) and Pfizer (NYSE: PFE) stand out. However, when deciding which of the two is the better high-yield dividend stock , you need to consider numerous criteria, not just the raw yield itself.
When it comes to today's yield, Pfizer is the clear victor. However, when considering whether the higher yield is sustainable, factors such as dividend payout ratios and earnings forecasts start to cast doubt.
Bristol-Myers Squibb Company
NASDAQ: BMY
BMY Trading
2.51% G/L:
$57.39 Last:
4,999,025 Volume:
$57.03 Open:
BMY Latest News
June 05, 2026 02:20:00 pm
Billionaire Izzy Englander Just Made a Big Bet on This Beaten-Down High-Yield Dividend Stock
BMY Stock Data
$123,325,918,376
2,034,328,000
N/A
1394
N/A
Pharmaceuticals
Healthcare
US
Princeton
